Evidence map›Paper›PMID 35360444›Full record

ArticleCanadian journal of gastroenterology & hepatology2022

Outcomes of Adult Liver Retransplantation: A Canadian National Database Analysis.

Peter D Yoon, Madhukar S Patel, Carla F Murillo Perez, Tommy Ivanics, Marco P A W Claasen, Hala Muaddi, David Wallace, Bettina Hansen, Gonzalo Sapisochin

Open access · goldAbstract read
In one paragraph

Article in Canadian journal of gastroenterology & hepatology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. LIVER RETRANSPLANTATION: PROGNOSTIC SCORES AND RESULTS IN THE STATE OF PARANÁ.Arquivos brasileiros de cirurgia digestiva : ABCD = Brazilian archives of digestive surgery · 2024
    Article
  7. The BAR Score Predicts and Stratifies Outcomes Following Liver Retransplantation: Insights From a Retrospective Cohort Study.Transplant international : official journal of the European Society for Organ Transplantation · 2024
    Article
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 6 countries.

Peter D YoonMulti-Organ Transplant Program, Toronto General Hospital, Toronto, Ontario, Canada.ORCID 0000-0002-7223-336X
Madhukar S PatelMulti-Organ Transplant Program, Toronto General Hospital, Toronto, Ontario, Canada.
Carla F Murillo PerezToronto Centre for Liver Disease, Toronto General Hospital, Toronto, Ontario, Canada.
Tommy IvanicsMulti-Organ Transplant Program, Toronto General Hospital, Toronto, Ontario, Canada.
Marco P A W ClaasenMulti-Organ Transplant Program, Toronto General Hospital, Toronto, Ontario, Canada.ORCID 0000-0001-8218-3119
Hala MuaddiMulti-Organ Transplant Program, Toronto General Hospital, Toronto, Ontario, Canada.
David WallaceMulti-Organ Transplant Program, Toronto General Hospital, Toronto, Ontario, Canada.
Bettina HansenToronto Centre for Liver Disease, Toronto General Hospital, Toronto, Ontario, Canada.
Gonzalo SapisochinMulti-Organ Transplant Program, Toronto General Hospital, Toronto, Ontario, Canada.
Toronto General Hospital · CAUniversity of Toronto · CAUppsala University Hospital · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Liver retransplantation remains as the only treatment for graft failure. This investigation aims to assess the incidence, post-transplant outcomes, and risk factors in liver retransplantation recipients in Canada. Materials and Methods: The Canadian Organ Replacement Register was used to obtain and analyse data on all adult liver retransplant recipients, matched donors, transplant-specific variables, and post-transplant outcomes from January 2000 to December 2018. Results: 377 (6.5%) patients underwent liver retransplantation. Autoimmune liver disease and hepatitis C virus (HCV) were the most common underlying diagnoses. Graft failure was 7.9% and 12.5%, and overall survival was 77.1% and 65.6% at 1 year and 5 years, respectively. In contrast to recipients receiving their first graft transplant, the retransplantation group had a significantly higher incidence of graft failure ( Conclusion: This analysis of liver retransplantation demonstrates that this is a safe treatment for early and late graft failure. Furthermore, even in patients requiring more than two grafts, similar outcomes to initial retransplantation can be achieved with careful selection.

Indexed as

Hepatitis CLiver TransplantationAdultCanadaHumansReoperation

Identifiers

PMID35360444
PMCPMC8964213
OpenAlexW4220964212

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.